Exploring the druggable space around the Fanconi anemia pathway using machine learning and mechanistic models
Marina Esteban‐MedinaiD, María Peña-ChiletiD, Carlos LouceraiD, Joaquı́n DopazoiD
Abstract
BackgroundIn spite of the abundance of genomic data, predictive models that describe phenotypes as a function of gene expression or mutations are difficult to obtain because they are affected by the curse of dimensionality, given the disbalance between samples and candidate genes. And this is especially dramatic in scenarios in which the availability of samples is difficult, such as the case of rare diseases.\n\nResultsThe application of multi-output regression machine learning methodologies to predict the potential effect of external proteins over the signaling circuits that trigger Fanconi anemia related cell functionalities, inferred with a mechanistic model, allowed us to detect over 20 potential therapeutic targets.\n\nConclusionsThe use of artificial intelligence methods for the prediction of potentially causal relationships between proteins of interest and cell activities related with disease-related phenotypes opens promising avenues for the systematic search of new targets in rare diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 41
- FWCI
- 3.56
- Field percentile
- top 6%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Knowledge Graphs and Explainable AI for Drug Repurposing on Rare Diseases
Pablo Perdomo-Quinteiro, Katherine Wolstencroft, … Núria Queralt-Rosiñach·bioRxiv·Oct 17, 2024
- Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)
Kavitha Agastheeswaramoorthy, Aarti Sevilimedu·bioRxiv·Sep 25, 2020
- COMIC: Explainable Drug Repurposing via Contrastive Masking for Interpretable Connections
Naafey Aamer, Muhammad Nabeel Asim, A. Dengel·BMC BioinformaticsPeer-reviewed·Jan 9, 2026
- An ensemble method for predicting and designing of druggable proteins.
Shipra Jain, Srijanee Gupta, Gajendra P. S. Raghava·PROTEOMICS - CLINICAL APPLICATIONSPeer-reviewed·May 1, 2026
- Prediction of drug targets for specific diseases leveraging gene perturbation data: A machine learning approach
Kai Zhao, Yujia Shi, Hon‐Cheong So·PharmaceuticsPeer-reviewed·Jan 20, 2022
- DeepPheno: Predicting single gene loss of function phenotypes
Maxat Kulmanov, Robert Hoehndorf·PLoS Computational BiologyPeer-reviewed·Nov 18, 2020